SLC2A4 and hyperlipidemia: Our previous research demonstrated that ATM potentially upregulates GLUT-4 and IRβ protein expression via the AMPK pathway, consequently ameliorating hyperlipidemia and insulin resistance in diabetic mice (Fu et al., 2020).